Acute Respiratory Distress Syndrome Induced by E-Cigarette or Vaping Product Use Associated Lung Injury
Article Sidebar
Main Article Content
Abstract
In 2019, a respiratory infection outbreak in individuals with a history of vaping was discovered, This condition was eventually termed e-cigarette or vaping product use–associated lung injury (EVALI) after it was linked to lung damage during imaging and histopathologic examination. The exact mechanism behind the lung injury seen in EVALI is unknown. Several studies show that EVALI has been associated with the incidence of acute respiratory distress syndrome. Nowadays, many people use Vapes/e-cigarettes, it is critical for clinicians to understand the hazards of using e-cigarettes, which can induce EVALI to ARDS. We used a number of research resources, including ScienceDirect, Google Scholar, PubMed, and Wiley, to search, select, and choose papers about the use of electronic cigarettes or vaping devices associated to lung injury trigger Acute Respiratory Distress syndrome. The literature search yielded 330 articles, of which 21 met the selection criteria based on the title and abstract. EVALI is still a clinical diagnosis that should be considered as an exclusion because the symptoms, physical examination, serologic, radiologic, and bronchoscopy results are not specific to the illness alone. ARDS and its sequelae may be more likely to occur in patients with EVALI who also have several chronic illnesses. For individuals who use excessively and consistently over weeks or months, there is strong correlative evidence suggesting a higher risk of VAPI and potential consequences from ARDS in the absence of prompt and aggressive therapy.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
A. Deshmukh et al., “Effect of metformin on outcomes of catheter ablation for atrial fibrillation,” J. Cardiovasc. Electrophysiol., vol. 32, no. 5, pp. 1232–1239, May 2021, doi: 10.1111/jce.14954.
L. Rottner et al., “Catheter Ablation of Atrial Fibrillation: State of the Art and Future Perspectives,” Cardiol. Ther., vol. 9, no. 1, pp. 45–58, Jun. 2020, doi: 10.1007/s40119-019-00158-2.
A. Saglietto, F. Gaita, R. De Ponti, G. M. De Ferrari, and M. Anselmino, “Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials,” Front. Cardiovasc. Med., vol. 8, p. 664647, May 2021, doi: 10.3389/fcvm.2021.664647.
A. Maharani, S. Wahyuni, and N. A. Hanum, “Gambaran Pengetahuan Tentang Pengaruh Rokok Elektrik Terhadap Kesehatan Gigi Dan Mulut Pada Komunitas Vapor Di Kota Palembang,” J. Kesehat. Gigi Dan Mulut, Vol. 3, No. 1, Pp. 44–47, Jul. 2021, Doi: 10.36086/Jkgm.V3i1.759.
J. V Freeman Et Al., “Outcomes And Anticoagulation Use After Catheter Ablation For Atrial Fibrillation,” Circ. Arrhythmia Electrophysiol., Vol. 12, No. 12, P. E007612, Dec. 2019, Doi: 10.1161/Circep.119.007612.
R. H. Isma’roj, M. H. Putri, Y. H. Praptiwi, And T. Sirait, “Gambaran Pengetahuan Dan Sikap Remaja Perokok Tentang Kesehatan Gigi Dan Mulut Di Desa Cibeber Kabupaten Lebak BANTEN,” J. Kesehat. Siliwangi, vol. 2, no. 1, pp. 309–313, 2021, doi: https://doi.org/10.34011/jks.v2i1.1857.
A. Supriatna and J. Angki, “Pengetahuan Remaja Tentang Pengaruh Merokok terhadap Kesehatan Gigi dan Mulut di Masyarakat di Desa Lotang Salo Kecematan Panca Rijang Kabupaten Sidenreng Rappang Tahun 2018,” Media Kesehat. Gigi Politek. Kesehat. Makassar, vol. 17, no. 2, 2018, doi: https://doi.org/10.32382/mkg.v17i2.660.
D. F. Islamiyah, S. Hidayati, and E. Purwaningsih, “Pengetahuan Siswa Perokok Tentang Kebersihan Gigi Dan Mulut (Studi pada Siswa Kelas 12 Jurusan Teknik Kendaraan Ringan SMK Bina Bangsa Dampit Malang Tahun 2022),” J. Ilm. Keperawatan Gigi, vol. 3, no. 3, pp. 398–406, 2022, doi: https://doi.org/10.37160/jikg.v3i3.980.
J. S. Steinberg et al., “Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension,” JAMA, vol. 323, no. 3, p. 248, Jan. 2020, doi: 10.1001/jama.2019.21187.
K. Rompis, V. N. S. Wowor, and D. H. C. Pangemanan, “Tingkat Pengetahuan Bahaya Merokok bagi Kesehatan Gigi Mulut pada Siswa SMK Negeri 8 Manado,” e-CliniC, vol. 7, no. 2, Jul. 2019, doi: 10.35790/ecl.v7i2.24023.
J. M. Lee et al., “The electrical isolation of the left atrial posterior wall in catheter ablation of persistent atrial fibrillation,” Clin. Electrophysiol., vol. 5, no. 11, pp. 1253–1261, 2019.
A. Quincho-Lopez, D. L. Quincho-Lopez, and F. D. Hurtado-Medina, “Case Report: Pneumothorax and Pneumomediastinum as Uncommon Complications of COVID-19 Pneumonia—Literature Review,” Am. J. Trop. Med. Hyg., vol. 103, no. 3, pp. 1170–1176, Sep. 2020, doi: 10.4269/ajtmh.20-0815.
F. Yi et al., “Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation,” J. Cardiovasc. Pharmacol., vol. 73, no. 4, pp. 241–247, Apr. 2019, doi: 10.1097/FJC.0000000000000654.
U. Desai, “Complication and Sequelae of Pulmonary Tuberculosis: A Tertiary Care Center Experience,” Int. J. Pulm. Respir. Sci., vol. 5, no. 5, Apr. 2022, doi: 10.19080/IJOPRS.2022.05.555674.
S. Tiberi et al., “Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation,” J. Bras. Pneumol., vol. 45, 2019.
H. Wu, J. Wei, and D. Yu, “Application of NGS in diagnosis of tuberculous pleurisy with multiple negative tests: a case report,” Infect. Drug Resist., pp. 3543–3550, 2020.
S. V Cherian, A. Kumar, and R. M. Estrada-Y-Martin, “E-Cigarette or Vaping Product-Associated Lung Injury: A Review,” Am. J. Med., vol. 133, no. 6, pp. 657–663, Jun. 2020, doi: 10.1016/j.amjmed.2020.02.004.
S. Krishnan et al., “A case of vaping-induced acute respiratory distress syndrome requiring extracorporeal life support,” Perfusion, vol. 36, no. 3, pp. 308–310, Apr. 2021, doi: 10.1177/0267659120925634.
A. Kalininskiy et al., “E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach,” Lancet Respir. Med., vol. 7, no. 12, pp. 1017–1026, Dec. 2019, doi: 10.1016/S2213-2600(19)30415-1.
P. W. Ind, “E-cigarette or vaping product use-associated lung injury,” Br. J. Hosp. Med., vol. 81, no. 4, pp. 1–9, Apr. 2020, doi: 10.12968/hmed.2019.0371.
M. E. Rebuli et al., “The E-cigarette or Vaping Product Use–Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report,” Ann. Am. Thorac. Soc., vol. 20, no. 1, pp. 1–17, 2023.
D. C. Christiani, “Vaping-induced acute lung injury,” New England Journal of Medicine, vol. 382, no. 10. Mass Medical Soc, pp. 960–962, 2020, doi: https://doi.org/10.5114/ait.2020.97989.
M. E. Rebuli et al., “The E-cigarette or Vaping Product Use–Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report,” Ann. Am. Thorac. Soc., vol. 20, no. 1, pp. 1–17, Jan. 2023, doi: 10.1513/AnnalsATS.202209-796ST.
M. Bizoń, D. Maciejewski, and J. Kolonko, “E-cigarette or vaping product use-associated acute lung injury (EVALI) as a therapeutic problem in anaesthesiology and intensive care departments,” Anaesthesiol. Intensive Ther., vol. 52, no. 3, pp. 219–225, 2020, doi: 10.5114/ait.2020.97989.
C. Fryman et al., “Acute Respiratory Failure Associated With Vaping,” Chest, vol. 157, no. 3, pp. e63–e68, Mar. 2020, doi: 10.1016/j.chest.2019.10.057.
M. J. Cecchini et al., “E-Cigarette or Vaping Product Use-Associated Lung Injury: A Review for Pathologists,” Arch. Pathol. Lab. Med., vol. 144, no. 12, pp. 1490–1500, Dec. 2020, doi: 10.5858/arpa.2020-0024-RA.
D. Hayes et al., “Pulmonary and Critical Care Considerations for e-Cigarette, or Vaping, Product Use-Associated Lung Injury,” Chest, vol. 162, no. 1, pp. 256–264, Jul. 2022, doi: 10.1016/j.chest.2022.02.039.
D. J. Cao et al., “Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury,” J. Med. Toxicol., vol. 16, no. 3, pp. 295–310, Jul. 2020, doi: 10.1007/s13181-020-00772-w.
N. M. Sakla, R. Gattu, G. Singh, and M. Sadler, “Vaping-associated acute respiratory distress syndrome,” Emerg. Radiol., vol. 27, no. 1, pp. 103–106, Feb. 2020, doi: 10.1007/s10140-019-01736-6.
A. Kalantary, B. Abdelazeem, N. Shams, R. Pratiti, and I. Al-Sanouri, “Coagulopathy and acute respiratory distress syndrome: Dual complications of E-cigarette-associated lung injury,” Cureus, vol. 13, no. 2, 2021.
D. Hayes Jr et al., “Pulmonary and critical care considerations for E-cigarette, or vaping, product use-associated lung injury,” Chest, vol. 162, no. 1, pp. 256–264, 2022, doi: https://doi.org/10.1016/j.chest.2022.02.039.